Measles surge causes alarm: what scientists think

Carissa Wong

DOI: https://doi.org/10.1038/d41586-024-00265-8

IF: 64.8

2024-02-01

Nature

Abstract:A drastic rise in infections in the United Kingdom and Europe follows a drop in vaccine uptake. A drastic rise in infections in the United Kingdom and Europe follows a drop in vaccine uptake.

multidisciplinary sciences

What problem does this paper attempt to address?

Measles rates are rising again

Helen Bedford,David Elliman

DOI: https://doi.org/10.1136/bmj.q259

2024-02-06

BMJ

Abstract:Decline in vaccine uptake must be reversed, urgently

medicine, general & internal
Measles: Warning given over low MMR uptake after cases rise to 200 in West Midlands

Gareth Iacobucci

DOI: https://doi.org/10.1136/bmj.q113

2024-01-17

BMJ

Abstract:Health officials have warned that a large increase in measles cases and hospital admissions in the West Midlands is being driven by low vaccination rates.Schools have been advised that any child who comes into contact with a case and who has not had at least one dose of the measles, mumps, and rubella vaccine should be excluded for 21 days to protect others.Provisional figures from the UK Health Security Agency show that as at 15 January the West Midlands had at least 198 laboratory confirmed cases of measles, with a further 104 cases likely. Around 80% of the cases are in Birmingham and 8% are in Coventry, with most occurring in children who were not vaccinated against measles, mumps and rubella, the UKHSA said.Birmingham Children's Hospital has seen more than 50 children needing treatment for measles in the past month, its highest number in decades.Measles incidence has been rising nationally...

medicine, general & internal
Measles outbreaks: Investing in patient relationships through GP continuity will be key to boosting MMR confidence

Emma Wilkinson

DOI: https://doi.org/10.1136/bmj.q221

2024-01-29

BMJ

Abstract:The World Health Organization has warned of an "alarming" and accelerating 30-fold increase in measles across Europe. On 19 January the UK Health Security Agency (UKHSA) declared a national incident in England amid spiralling cases and a drop in vaccine uptake.Andrew Wakefield's fraudulent and long discredited research linking the measles, mumps, and rubella (MMR) vaccine with autism has cast a long shadow. It remains part of the picture but the reasons behind falling vaccine rates are now more complex, GPs and public health doctors say.Last year only 84.5% of 5 year olds in England had had both doses of the MMR vaccine, a figure that hides pockets of particularly low coverage. In Birmingham, the epicentre of the current measles outbreak, uptake was 75%. There are boroughs in London—where isolated outbreaks have also been reported—where only 60% of children are fully vaccinated. Because measles is so infectious, 95% coverage is needed...

medicine, general & internal
Measles Resurgence in Europe: Migrants and Travellers are not the Main Drivers

Wei-Yee Leong,Annika Beate Wilder-Smith

DOI: https://doi.org/10.2991/jegh.k.191007.001

Abstract:Measles is a highly transmissible viral infection that may lead to serious illness, lifelong complications, and death. As there is no animal reservoir for measles, measles resurgence is due to human movement of viremic persons. Therefore, some have blamed the enormous migration into Europe in the past 5 years for the measles resurgence in this region. We set out to determine the main driver for measles resurgence in Europe by assessing vaccine coverage rates and economic status in European countries, number of migrants, and travel volumes. Data on measles vaccine coverage rates with two vaccine doses of measles, mumps and rubella (MMR) [Measles Containing Vaccine (MCV)2] and total number of measles cases in 2017 for Europe, including Eastern European countries, were obtained, in addition to Gross Domestic Product (GDP), and number of migrants and tourist arrivals. The outcome measured, incidence of measles per 100,000, was log transformed and subsequently analyzed using multiple linear regression, along with predictor variables: number of international migrants, GDP per capita, tourist arrivals, and vaccine coverage. The final model was interpreted by exponentiating the regression coefficients. Incidence of measles was highest in Romania (46.1/100,000), followed by Ukraine (10.8/100,000) and Greece (8.7/100,000). MCV2 coverage in these countries is less than 84%, with lowest coverage rate (75%) reported in Romania. Only vaccine coverage appears to be the significant predictor in the model (p < 0.001) for incidence of measles even after adjusting for international migrants, international tourist arrivals, and GDP per capita. With one unit increase in vaccination coverage, the incidence of measles decreased by 18% [95% confidence interval (CI): 10-25]. Our results showed that number of migrants and international tourist arrivals into any of the European countries were not the drivers for increased measles cases. Countries with high vaccine coverage rates regardless of economic status did not experience a resurgence of measles, even if the number of migrants or incoming travellers was high. The statistically significant sole driver was vaccine coverage rates. These analyses reemphasize the importance of strategies to improve national measles vaccination to achieve coverage greater than 95%.
Global resurgence of measles in the vaccination era and influencing factors

Subekshya Bidari,Wan Yang

DOI: https://doi.org/10.1016/j.ijid.2024.107189

Abstract:Objectives: Recent years have seen increased cases of measles despite widespread vaccination. We examined the potential drivers behind the resurgence of measles. Methods: We analyzed the trends in measles incidence and vaccine coverage from 2010 to 2019 across World Health Organization member countries using country-level linear regression models. We computed the Spearman rank correlation coefficient (ρ) between measles incidence and socioeconomic and vaccination-related variables using published data from the World Health Organization member countries to identify the key factors influencing measles incidence. Results: Between 2010 and 2019, global measles cases fluctuated, with a notable rise in 2019 (measles cases per million in 2019 was about 140% higher than in 2010), alongside a declining vaccination coverage in many countries (59 of 194 countries). Among 10 socioeconomic factors examined, per-capita national gross income, population literacy, urban residences, and political stability were significantly associated with measles incidence (ρ <0, and P <0.05 for all these variables). These factors likely reflect the quality of public health infrastructure (e.g. access to vaccines), particularly, in low- and middle-income countries. In addition, a stratified analysis suggests vaccine hesitancy likely contributed to measles case increases in high- and upper middle-income countries. Conclusions: The socioeconomic determinants of measles transmission are interconnected and region-specific. The availability of public health resources and political stability significantly influence measles burdens in low- and middle-income countries, whereas vaccine hesitancy presents a unique challenge to measles elimination in high- and upper middle-income countries.
Measles: Birmingham outbreak declared a national incident and likely to spread

Jacqui Wise

DOI: https://doi.org/10.1136/bmj.q159

2024-01-20

BMJ

Abstract:Outbreaks of measles will spread to other towns and cities in the UK without urgent action to increase measles, mumps, and rubella (MMR) vaccination uptake, the UK Health Security Agency (UKHSA) has warned.On 19 January the agency declared the current outbreak in Birmingham1 a national incident, allowing it to put more resources into tackling the problem.2As of 18 January there have been 216 confirmed cases and 103 probable cases in the west Midlands since 1 October 2023. Around 80% of those cases have been in Birmingham, with 10% in Coventry, UKHSA said. Most are in children under 10 years old.On a visit to Birmingham, Jenny Harries, chief executive of UKHSA, said, "Colleagues across the west Midlands have worked tirelessly to try to control the outbreak, but with vaccine uptake in some communities so low there is now a very real risk of seeing the virus spread to other towns and...

medicine, general & internal
Analysis reveals global post-covid surge in infectious diseases

Jane Feinmann

DOI: https://doi.org/10.1136/bmj.q1348

2024-06-20

BMJ

Abstract:A large post-covid global surge in common communicable diseases including influenza, measles, tuberculosis, and whooping cough has been identified in a new analysis of data from 60 organisations and public health agencies.Since the beginning of 2022, 44 countries have experienced a 10-fold increase in the incidence of at least one of 13 infectious diseases compared with a pre-pandemic baseline, according to the analysis1 by the UK based disease forecasting firm Airfinity and the US news website Bloomberg.Experts said that with no historical precedent, they can't fully explain the resurgence in infectious diseases.Jeremy Farrar, World Health Organization chief scientist, told The BMJ, "We've not had an acute, fast moving, and devastating pandemic in the modern scientific era. The last major devastating pandemic was in 1918 when there was no vaccination, no diagnostics or treatments. We're in new territory here."Airfinity scientists said, however, that declining vaccine rates during the pandemic, notably for...

medicine, general & internal
Trends of the Global, Regional, and National Incidence of Measles, Vaccine Coverage, and Risk Factors in 204 Countries From 1990 to 2019

Ruitong Wang,Wenzhan Jing,Min Liu,Jue Liu

DOI: https://doi.org/10.3389/fmed.2021.798031

2022-01-20

Abstract:Background: Measles is a highly contagious disease that has caused global morbidity and mortality. Though great progress has been made in measles elimination, the resurgence of measles has been observed in recent years. As extant literature were mainly confined to data of local area, we conducted a systematic analysis to explore the trends of the incidence of measles, coverage rate, and the risk factors from 1990 to 2019 on global, regional, and national levels. Methods: Data on cases of incidence, age standardized rate (ASR), vaccine coverage, and risk factors of measles were retrieved from the Global Burden of Disease (GBD) Study 2019 database. Estimated averaged percentage change (EAPC) of ASR was calculated to quantify the trends of measles incidence. Pearson correlation was applied to assess the association of EAPC and measles-containing vaccine coverage rate with socio-demographic index (SDI) in 2019, and the correlation between ASR and measles-containing vaccine coverage rate. Results: Globally, there was a significant decrease in the number (84.18%) and ASR (6.13%, 95% CI: 5.41-6.84%) of measles incidence from 1990 to 2019. More than 80% of incidence cases were attributed to children under 5 and the proportion was highest in low SDI region. Countries and territories with low ASRs are mostly clustered in North America, Southern Latin America, and Western Europe, whereas those with high ASRs are mainly clustered in Africa, East Asia, and South Asia. Lower SDI was associated with higher ASR and lower vaccine coverage rate. The more the SDI value was further away from 0.6, the smaller the absolute value did EAPC have. Child wasting accounted for the most measles-related death cases, followed by child underweight, child stunting, and vitamin A deficiency. Conclusions: Measles eradication is feasible, but urgently demands political commitment, financial support, and public engagement. In the context of COVID-19 pandemic and the global resurgence of measles, surveillance systems and routine immunization programs should be improved, while vaccine hesitancy needs to be addressed.
Measles: Man dies in Ireland, while cases in West Midlands remain "disproportionately high"

Jacqui Wise

DOI: https://doi.org/10.1136/bmj.q359

2024-02-10

BMJ

Abstract:A man has died in hospital in Ireland after contracting measles, the country's Health Service Executive has confirmed.1 Irish media have reported that the man, in his late 40s, had recently travelled to Birmingham, where cases of measles are continuing to rise.The UK Health Security Agency said, "A disproportionately high rate continues to be seen in the West Midlands, with a sharp rise in case numbers over the last six weeks, mainly driven by cases in Birmingham."On 8 February the Irish Health Protection Surveillance Centre confirmed that an adult with confirmed measles died in a hospital in the Dublin and Midlands health region.2It is the first measles case notified in Ireland in 2024. Four cases were reported in 2023, two in 2022, none in 2021, and five in 2020. No deaths were reported in any of these years.The Health Service Executive has set up a measles national incident management team...

medicine, general & internal
Ongoing Measles in the Developed and Developing World

James D Cherry

DOI: https://doi.org/10.1093/jpids/piae018

2024-02-29

Journal of the Pediatric Infectious Diseases Society

Abstract:Abstract Measles is a vaccine preventable illness. Nevertheless, in recent years, measles is still endemic and epidemic in both the developed world and the developing world. The public perception of measles in the past was that it was not a big deal. However, measles is associated with a number of complications which can be places in three categories which are: acute(diarrhea, otitis media, pneumonia, encephalitis, seizures, and death) and delayed-subacute sclerosing panencephalitis (SSPE) and post measles immune amnesia. Contrary to the beliefs of the anti-vaccine lobby, measles is bad. In acute measles, the death rate is 1-3 per 1000 and the risk of encephalitis is 1 per 1000. Relatively recent investigations indicate that SSPE is considerably more common than previously believed. The worldwide contribution of post measles immune amnesia to morbidity and mortality is likely to be huge. In exposure situations two doses of measles vaccine will prevent 99% of cases. Presently in the United States the first dose is given at 12 through 15 months of age. The second dose is most often administered at 4 through 6 years of age. In my opinion, the second dose of measles vaccine should be given 4 to 6 weeks after the first dose rather than at 4 to 6 years of age. Children who don’t have antibody to measles should not travel to risk areas.

pediatrics,infectious diseases
An upsurge of measles cases in Mali – a consequence of pandemic-associated disruption in routine immunization

Nginache Nampota-Nkomba,Adama Mamby Keita,Jane Juma,Diakaridia Sidibe,Nana Kourouma,Seydou Sissoko,Fadima Cheick Haidara,Cheick Tidiane Traore,Cheick Bougadari Traore,Awa Traore,Brigitte Gaume,Samba Ousmane Sow,Karen L Kotloff,Milagritos D Tapia,Samba Ousemane Sow

DOI: https://doi.org/10.1093/ofid/ofae154

2024-03-19

Open Forum Infectious Diseases

Abstract:Abstract Measles deaths highlight immunization program gaps. In the Child Health and Mortality Prevention Surveillance study in Mali, we observed a rise in under-5 measles-related deaths in 2022 which corresponded with increased measles cases at the same time and a decline in measles vaccine coverage in Mali in 2020.

immunology,infectious diseases,microbiology
Measles: Millions of children missed routine vaccination last year, WHO and CDC warn

Carla Delgado

DOI: https://doi.org/10.1136/bmj.q2541

2024-11-20

BMJ

Abstract:Inadequate vaccination coverage drove the number of measles cases to an estimated 10.3 million worldwide in 2023, the World Health Organization and the US Centers for Disease Control and Prevention have said in a joint report.1Coverage of at least 95% of children with two doses of the vaccine is needed to prevent outbreaks and protect communities. However, over 22 million children missed the first dose of a measles containing vaccine (MCV1) last year, reporting an immunity gap that stands in the way of elimination of the disease, said the report, published on 14 November.The estimated global coverage of MCV1 reached a peak of 86% in 2019, before declining to 81% in 2021 because of the covid-19 pandemic. Although coverage improved to 83% in 2022, it remained unchanged in 2023. No WHO region has regained its peak coverage levels.If vaccination coverage does not outpace a rapidly growing population, the number of...

medicine, general & internal
Low percentages of measles vaccination coverage with two doses of vaccine and low herd immunity levels explain measles incidence and persistence of measles in the European Union in 2017–2018

Pedro Plans-Rubió

DOI: https://doi.org/10.1007/s10096-019-03604-0

2019-07-10

Abstract:Several factors may explain why measles persisted in the European Union in 2017–2018. The study assessed mean measles vaccination coverage and anti-measles herd immunity levels in the target measles vaccination population in countries of the European Union during the 2015–2017 period. The study found that the measles vaccination coverage with two doses of vaccine was < 95% in 28 (96.5%) countries, and that the prevalence of individuals with vaccine-induced measles protection in the target vaccination population was lower than the herd immunity threshold of 94.4% in 22 (75.9%) countries during 2015–2017. The study found a significant negative correlation between the incidence of measles in 2017–2018 in different countries of the European Union and measles vaccination coverage with two doses of measles vaccine, prevalence of individuals with vaccine-induced measles protection and herd immunity levels in the target measles vaccination population during 2015–2017. Measles vaccination coverage and herd immunity levels did not improve from 2010–2015 to 2015–2017 in the European Union. Low percentages of measles vaccination coverage with two doses of vaccine and low herd immunity levels could explain measles incidence in countries of the European Union in 2017–2018. New measles prevention strategies should be developed to increase measles vaccination coverage and herd immunity levels in the European Union.

infectious diseases,microbiology
The Resurgence of Measles: A Rash From the Past

Michael D Gooch

DOI: https://doi.org/10.1097/TME.0000000000000521

Abstract:Measles, or rubeola, remains a highly contagious infectious disease with a concerning resurgence in the United States. Despite previous control efforts, the number of reported cases continues to rise, surpassing the total for the previous year in just the first quarter of 2024 (CDC, 2024a). Emergency nurse practitioners and other emergency clinicians are likely to encounter patients presenting with concerns of or exposure to measles. However, given the low frequency of cases in the past, many emergency clinicians have likely not previously encountered measles, making identification more challenging. Early recognition and isolation are paramount in containing the spread of this virus and mitigating potential complications. This article aims to provide a review of measles, covering its pathophysiology, clinical presentations, and recommended management strategies for suspected or confirmed cases in emergency care settings.
Measles outbreak in 2019: a warning for the post-COVID-19 pandemic period

Irma Salimović-Bešić,Sanjin Musa,Šejla Kotorić-Keser,Edina Zahirović,Selma Mutevelić,Amela Dedeić-Ljubović

DOI: https://doi.org/10.1099/jmm.0.001855

2024-07-14

Journal of Medical Microbiology

Abstract:Introduction. At the end of 2019 and the year before, there was a significant spread of measles in the World Health Organization (WHO) European Region. Gap statement. Among the countries that reported, a measles outbreak was Bosnia and Herzegovina (BiH). Aim. To describe the measles outbreak in BiH (an entity of the Federation of BiH, FBiH) in 2019. Methodology. Confirmatory IgM serology, measles nucleic acid detection by real-time RT-PCR and virus genotyping were done in the WHO-accredited laboratory for measles and rubella at the Clinical Center of the University of Sarajevo, Unit for Clinical Microbiology. Genotype was determined in all measles-RNA-positive cases by sequence analysis of the 450 nt fragment coding the C-terminal of measles virus nucleoprotein (N). Results. From 1 January to 31 December 2019, 1332 measles cases were reported, with the peak observed in April 2019 (413/1332, 31.01 %). Sarajevo Canton had the highest incidence, number of cases and percentage (206.4; 868/1332; 65.17 %) of measles cases. Around four-fifths of infected persons were unvaccinated (1086/1332, 81.53 %), while 4.58 % of the patients (61/1332) were immunized with one dose of measles-containing vaccine. The highest proportion of cases was found in children 0–6 years of age (738/1332, 55.41 %). Measles IgM positivity was determined in 75.88 % (346/456), while virus RNA was detected in 82.46 % (47/57) of the swab samples. All measles virus sequences belonged to genotype B3. SNP (position 216: C=>T) was detected in 1 of the 40 sequences obtained during this outbreak. Conclusion. Due to suboptimal immunization coverage, BiH belongs to countries at a high risk for measles outbreaks. Post-COVID-19 (coronavirus disease 2019) pandemic, targeted and tailored strategies are required to ensure routine vaccination demand and acceptance and broad partner and stakeholder group participation.

microbiology
The Case for Assessing the Drivers of Measles Vaccine Uptake

Jessica Kaufman,Ashleigh Rak,Sophia Vasiliadis,Navrit Brar,Eeman Atif,Jennifer White,Margie Danchin,David N. Durrheim

DOI: https://doi.org/10.3390/vaccines12060692

2024-06-21

Vaccines

Abstract:Global measles cases are on the rise following disruptions to routine immunisation programs during the COVID-19 pandemic, with devastating consequences. According to the World Health Organization, the behavioural and social drivers of vaccination include what people think and feel about vaccines, social processes, motivation to vaccinate and practical barriers to vaccination. However, the drivers of measles vaccine uptake are not necessarily the same as those for other childhood vaccines, and we lack data on how these drivers specifically have changed during and since the COVID-19 pandemic. Without accurately measuring the behavioural and social drivers for measles vaccination, and ideally measuring them serially over time, countries cannot design, target and implement interventions that effectively increase and sustain measles vaccine coverage. This paper outlines what is and is not known about the behavioural and social drivers of measles vaccination and provides recommendations for improving their post-pandemic assessment.

immunology,medicine, research & experimental
A Call to Action: Strengthening Vaccine Confidence in the United States

Sarah Mbaeyi,Amanda Cohn,Nancy Messonnier

DOI: https://doi.org/10.1542/peds.2020-0390

2020-05-27

PEDIATRICS

Abstract:* Abbreviation: CDC — : Centers for Disease Control and PreventionIn the United States and around the world, measles (a serious, potentially fatal, and extremely contagious infection) was considered a disease of the past until recently. However, what was once old news is now making headlines again with a remarkably predictable storyline: when immunity to measles falls in a population, outbreaks soon follow. This scenario has unfolded in places such as Ukraine, the Philippines, Israel, and Samoa with devastating consequences.1 In 2019 alone, the United Kingdom and 3 other European countries lost measles elimination status in part because of vaccine hesitancy, or the delay in acceptance or the refusal of vaccination despite availability of vaccination services, which was named one of the top global public health threats by the World Health Organization. Amid this global measles resurgence, the United States experienced a chain reaction of measles cases imported into close-knit, undervaccinated communities (primarily by unvaccinated US residents carrying measles home from outbreaks abroad), leading to outbreaks across the country in 2018 and 2019. These outbreaks were fueled by targeted vaccine misinformation and resulted in the highest number of measles cases in almost 30 years, nearly costing the United States its measles elimination status.2 To protect our nation, we need to change this narrative. We must empower families, in all … Address correspondence to Sarah Mbaeyi, MD, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mail Stop H24-8, Atlanta, GA 30329. E-mail: smbaeyi{at}cdc.gov

pediatrics
Measles outbreak in Western Uganda: a case-control study

Abel Wilson Walekhwa,Moses Ntaro,Peter Chris Kawungezi,Chiara Achangwa,Rabbison Muhindo,Emmanuel Baguma,Michael Matte,Richard Migisha,Raquel Reyes,Peyton Thompson,Ross M. Boyce,Edgar M. Mulogo

DOI: https://doi.org/10.1186/s12879-021-06213-5

IF: 3.7

2021-06-22

BMC Infectious Diseases

Abstract:Abstract Background Measles outbreaks are prevalent throughout sub-Saharan Africa despite the preventive measures like vaccination that target under five-year-old children and health systems strengthening efforts like prioritizing the supply chain for supplies. Measles immunization coverage for Kasese district and Bugoye HC III in 2018 was 72 and 69%, respectively. This coverage has been very low and always marked red in the Red categorization (below the national target/poor performing) on the national league table indicators. The aim of this study was to assess the scope of the 2018–2019 measles outbreak and the associated risk factors among children aged 0–60 months in Bugoye sub-county, Kasese district, western Uganda. Methods We conducted a retrospective unmatched case-control study among children aged 0–60 months with measles (cases) who had either a clinical presentation or a laboratory confirmation (IgM positivity) presenting at Bugoye Health Centre III (BHC) or in the surrounding communities between December 2018 and October 2019.. Caregivers of the controls (whose children did not have measles) were selected at the time of data collection in July 2020. A modified CDC case investigation form was used in data collection. Quantitative data was collected and analyzed using Microsoft excel and STATA version 13. The children’s immunization cards and health registers at BHC were reviewed to ascertain the immunization status of the children before the outbreak. Results An extended measles outbreak occurred in Bugoye, Uganda occured between December 2018 and October 2019. All 34 facility-based measles cases were documented to have had maculopapular rash, conjunctivitis, and cough. Also, the majority had fever (97%), coryza (94.1%), lymphadenopathy (76.5%), arthralgias (73.5%) and Koplik Spots (91.2%) as documented in the clinical registers. Similar symptoms were reported among 36 community-based cases. Getting infected even after immunized, low measles vaccination coverage were identified as the principal risk factors for this outbreak. Conclusion Measles is still a significant problem. This study showed that this outbreak was associated with under-vaccination. Implementing a second routine dose of measles-rubella vaccine would not only increase the number of children with at least one dose but also boost the immunity of those who had the first dose.

infectious diseases
Precise mapping reveals gaps in global measles vaccination coverage

C. Edson Utazi,Andrew J. Tatem

DOI: https://doi.org/10.1038/d41586-020-03391-1

IF: 64.8

2020-12-16

Nature

Abstract:Improved access to childhood vaccines has been one of the biggest breakthroughs in public health in recent decades, as evidenced by the eradication of smallpox in 1980 and this year's declaration of Africa as polio-free<a href="#ref-CR1">1</a>. But for measles, the road towards elimination and eradication has been bumpy, despite the existence of a safe and cost-effective vaccine. Measles cases and deaths persist, particularly in low- and middle-income countries (LMICs; see <a href="http://go.nature.com/37raIbw">go.nature.com/37raIbw</a>), where many factors — from conflict to vaccine hesitancy and underfunding — continue to pose challenges to immunization. <a href="https://www.nature.com/articles/s41586-020-03043-4">Writing in Nature</a><a href="#ref-CR2">2</a>, a group called the Local Burden of Disease Vaccine Coverage Collaborators provides evidence that targets for measles vaccination are in jeopardy, owing to major inequities in coverage, together with the slowdown, stagnation and regression of the coverage of routine first-dose measles vaccines between 2010 and 2019.

multidisciplinary sciences
Measles Cases Are Spreading in the US—Here’s What to Know

Melissa Suran

DOI: https://doi.org/10.1001/jama.2024.1949

IF: 11.816

2024-02-28

JAMA

Abstract:This Medical News article discusses measles cases spreading in the US.

medicine, general & internal

Measles surge causes alarm: what scientists think

Measles rates are rising again

Measles: Warning given over low MMR uptake after cases rise to 200 in West Midlands

Measles outbreaks: Investing in patient relationships through GP continuity will be key to boosting MMR confidence

Measles Resurgence in Europe: Migrants and Travellers are not the Main Drivers

Global resurgence of measles in the vaccination era and influencing factors

Measles: Birmingham outbreak declared a national incident and likely to spread

Analysis reveals global post-covid surge in infectious diseases

Trends of the Global, Regional, and National Incidence of Measles, Vaccine Coverage, and Risk Factors in 204 Countries From 1990 to 2019

Measles: Man dies in Ireland, while cases in West Midlands remain "disproportionately high"

Ongoing Measles in the Developed and Developing World

An upsurge of measles cases in Mali – a consequence of pandemic-associated disruption in routine immunization

Measles: Millions of children missed routine vaccination last year, WHO and CDC warn

Low percentages of measles vaccination coverage with two doses of vaccine and low herd immunity levels explain measles incidence and persistence of measles in the European Union in 2017–2018

The Resurgence of Measles: A Rash From the Past

Measles outbreak in 2019: a warning for the post-COVID-19 pandemic period

The Case for Assessing the Drivers of Measles Vaccine Uptake

A Call to Action: Strengthening Vaccine Confidence in the United States

Measles outbreak in Western Uganda: a case-control study

Precise mapping reveals gaps in global measles vaccination coverage

Measles Cases Are Spreading in the US—Here’s What to Know